NO20073547L - Nikotinacetykolinreseptorligander - Google Patents

Nikotinacetykolinreseptorligander

Info

Publication number
NO20073547L
NO20073547L NO20073547A NO20073547A NO20073547L NO 20073547 L NO20073547 L NO 20073547L NO 20073547 A NO20073547 A NO 20073547A NO 20073547 A NO20073547 A NO 20073547A NO 20073547 L NO20073547 L NO 20073547L
Authority
NO
Norway
Prior art keywords
nikotinacetykolinreseptorligander
diastereoisomers
enantiomers
formula
preparation
Prior art date
Application number
NO20073547A
Other languages
English (en)
Norwegian (no)
Inventor
Richard Schmiesing
Robert Jacobs
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20073547L publication Critical patent/NO20073547L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20073547A 2004-12-16 2007-07-09 Nikotinacetykolinreseptorligander NO20073547L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63668004P 2004-12-16 2004-12-16
PCT/SE2005/001919 WO2006065217A1 (fr) 2004-12-16 2005-12-14 Ligands des recepteurs nicotiniques de l'acetylcholine

Publications (1)

Publication Number Publication Date
NO20073547L true NO20073547L (no) 2007-08-01

Family

ID=36588167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073547A NO20073547L (no) 2004-12-16 2007-07-09 Nikotinacetykolinreseptorligander

Country Status (13)

Country Link
US (1) US20080103170A1 (fr)
EP (1) EP1831212A4 (fr)
JP (1) JP2008524212A (fr)
KR (1) KR20070086273A (fr)
CN (1) CN101119994A (fr)
AU (1) AU2005317235A1 (fr)
BR (1) BRPI0518547A2 (fr)
CA (1) CA2592321A1 (fr)
IL (1) IL183598A0 (fr)
MX (1) MX2007007024A (fr)
NO (1) NO20073547L (fr)
WO (1) WO2006065217A1 (fr)
ZA (1) ZA200705106B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2974365B1 (fr) * 2011-04-20 2017-08-25 Centre Nat De La Rech Scient (C N R S) 1,2,3-triazoles 1,4-disubstituees, leurs procedes de preparation et leurs utilisations diagnostiques et therapeutiques
WO2016154434A1 (fr) * 2015-03-25 2016-09-29 The Regents Of The University Of California Agonistes sélectifs du récepteur nicotinique alpha-7 et leurs procédés de fabrication et d'utilisation
WO2023213739A1 (fr) * 2022-05-05 2023-11-09 Philip Morris Products S.A. Ligands du récepteur nicotinique de l'acétylcholine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
US5041450A (en) * 1988-06-29 1991-08-20 Research Corporation Technologies, Inc. Treatment of ocular inflammation
US5135935A (en) * 1991-05-17 1992-08-04 Merck & Co., Inc. Squalene synthetase inhibitors
DE60311853T2 (de) * 2002-09-30 2007-06-21 Neurosearch A/S Neue 1,4-diazabicycloalkanderivate, deren herstellung und verwendung
SE0303076D0 (sv) * 2003-11-19 2003-11-19 Astrazeneca Ab 5-substituted imidazoles
SE0303075D0 (sv) * 2003-11-19 2003-11-19 Astrazeneca Ab 4-substituted imidazoles

Also Published As

Publication number Publication date
WO2006065217A1 (fr) 2006-06-22
MX2007007024A (es) 2007-07-04
EP1831212A4 (fr) 2010-01-13
IL183598A0 (en) 2007-09-20
CN101119994A (zh) 2008-02-06
BRPI0518547A2 (pt) 2008-11-25
JP2008524212A (ja) 2008-07-10
AU2005317235A1 (en) 2006-06-22
EP1831212A1 (fr) 2007-09-12
US20080103170A1 (en) 2008-05-01
KR20070086273A (ko) 2007-08-27
CA2592321A1 (fr) 2006-06-22
ZA200705106B (en) 2008-12-31

Similar Documents

Publication Publication Date Title
NO20073551L (no) Nikotinacetylkolinreseptorligander
NO20084915L (no) Nikotinacetylcholinreseptorligander 101
NO20084129L (no) Pyridin(3,4-B)Pyrazinoner
NO20074703L (no) Antibakterielle piperidinderivater
SE0401971D0 (sv) Piperidne derivatives
WO2006067614A3 (fr) Derives heteroaromatiques utiles en tant qu'agents anticancereux
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20063354L (no) Nikotinacetylcholinreseptorligander
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
TW200639156A (en) New compounds
SE0401762D0 (sv) Novel compounds
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20080033L (no) Kinolinderivater som NK3-antagonister
SG170054A1 (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
PL1831191T3 (pl) Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT
MX2010009756A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
WO2008104473A3 (fr) Inhibiteurs de kinase et procédés d'utilisation de ces derniers
NO20063619L (no) Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
NO20073547L (no) Nikotinacetykolinreseptorligander
NO20082589L (no) Nye indolizinderivater, fremgangsmate for fremstilling av samme og terapeutiske sammensetninger som inbefatter samme
NO20053805L (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
IL181666A0 (en) Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
NO20081862L (no) Alkylsulfoksidkinoliner som NK-3-reseptorligander

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application